| FGDMX | FGEMX | FGDMX / FGEMX | |
| Total Expense Ratio | 0.96 | 1.21 | 79% |
| Annual Report Gross Expense Ratio | 0.96 | 1.21 | 79% |
| Fund Existence | 7 years | 7 years | - |
| Gain YTD | 32.807 | 32.729 | 100% |
| Front Load | 6% | 4% | 164% |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.64B | 2.64B | 100% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 23.24 | 23.11 | 101% |
| Returns for 3 years | 152.38 | 150.79 | 101% |
| Returns for 5 years | 76.00 | 74.25 | 102% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JDISX | 17.99 | 0.16 | +0.90% |
| JHancock Disciplined Value Intl R2 | |||
| DRDIX | 24.79 | 0.20 | +0.81% |
| Dearborn Partners Rising Dividend I | |||
| LHCOX | 23.12 | 0.13 | +0.57% |
| Lord Abbett Health Care F3 | |||
| RLITX | 16.67 | 0.07 | +0.42% |
| Lazard International Strategic Eq R6 | |||
| LFGTX | 43.61 | -0.12 | -0.27% |
| Lord Abbett Focused Growth R5 | |||